STL427944 was found to block FOXM1 activity by inducing the relocalization of nuclear FOXM1 to the cytoplasm and promoting its autophagic degradation, it sensitizes various cancer cells to multiple traditionally used chemotherapies at very high concentrations [5]. The gene discussed is FOXM1; the disease is cancer.